Head Cancer Treatment Details providing a coordinated view of therapies, goals, and supportive care.

Cancer involves abnormal cells growing uncontrollably, invading nearby tissues, and spreading to other parts of the body through metastasis. 

We're Here to Help.
Get in Touch.

Send us all your questions or requests, and our expert team will assist you.

Doctors
GDPR

Treatment Details for Head Cancer at Liv Hospital

Head Cancer

Understanding the Treatment Details for head cancer is essential for patients and families navigating complex therapeutic pathways. At Liv Hospital, a JCI‑accredited international center in Istanbul, we combine cutting‑edge technology with a patient‑centered approach to deliver personalized care for every stage of disease. Each year, more than 10,000 patients travel to Turkey for advanced oncology services, and head and neck malignancies represent a significant portion of these referrals. This page outlines the full spectrum of treatment options, from precise diagnostics to multidisciplinary surgery, radiation, systemic therapies, and comprehensive rehabilitation, ensuring you have a clear roadmap to recovery.

Whether you are seeking a second opinion, planning a treatment journey from abroad, or looking for detailed information on the latest therapeutic advances, the following sections provide an in‑depth guide. Our international patient services team assists with appointments, travel logistics, interpreter support, and comfortable accommodation, allowing you to focus solely on healing.

Overview of Head Cancer Types and Staging

Transoral Robotic Surgery (TORS)

Head cancer encompasses a diverse group of malignancies arising in the skull, brain, sinuses, oral cavity, and surrounding structures. The most common subtypes include glioblastoma, meningioma, nasopharyngeal carcinoma, and salivary gland tumors. Accurate staging is pivotal because it dictates the therapeutic strategy and prognosis. The American Joint Committee on Cancer (AJCC) staging system evaluates tumor size (T), nodal involvement (N), and distant metastasis (M), creating a unified framework for clinicians worldwide.

Key factors influencing stage assignment:

  • Location and extent of the primary lesion
  • Involvement of cranial nerves or vascular structures
  • Presence of regional lymph node enlargement
  • Evidence of distant spread on imaging or biopsy

Below is a simplified table illustrating typical stage categories for a representative head and neck cancer:

Stage

Tumor (T)

Nodes (N)

Metastasis (M)

 

Stage I

T1 – ≤2 cm

N0

M0

Stage II

T2 – >2 cm but ≤4 cm

N0

M0

Stage III

T3 – >4 cm or minor bone involvement

N1 – single ipsilateral node ≤3 cm

M0

Stage IV

T4 – extensive invasion

N2/N3 – multiple or larger nodes

M1 – distant spread

Understanding these categories helps patients anticipate the intensity of Treatment Details they may encounter and facilitates clear communication with the care team.

Multidisciplinary Diagnostic Approach

Accurate diagnosis begins with a coordinated, multidisciplinary effort that integrates imaging, pathology, and clinical expertise. At Liv Hospital, a dedicated tumor board convenes weekly, bringing together neurosurgeons, radiation oncologists, medical oncologists, radiologists, and specialized nurses to review each case.

Core diagnostic components include:

  • Magnetic Resonance Imaging (MRI) with contrast to delineate soft‑tissue involvement and peritumoral edema.
  • High‑resolution Computed Tomography (CT) for bone assessment and surgical planning.
  • Positron Emission Tomography (PET‑CT) to detect metabolic activity and potential distant metastases.
  • Image‑guided core needle or stereotactic biopsy for histopathological confirmation.
  • Genomic profiling to identify actionable mutations for targeted therapy.

Each diagnostic modality is selected based on tumor location, patient health status, and the need for precise mapping before intervention. The resulting comprehensive report becomes the foundation for personalized Treatment Details, ensuring that surgical, radiation, and systemic options are aligned with the tumor’s biology.

Icon LIV Hospital

Surgical Treatment Options

Immunotherapy and the Durable Response

Surgery remains a cornerstone for many head cancer subtypes, particularly when the disease is localized and resectable. Liv Hospital employs state‑of‑the‑art techniques, including image‑guided navigation, intra‑operative MRI, and robotic assistance, to maximize tumor removal while preserving critical functions such as speech, swallowing, and vision.

Primary surgical approaches:

  • Craniotomy for intracranial tumors, enabling direct access to brain tissue.
  • Transnasal endoscopic surgery for sinonasal and skull‑base lesions, minimizing external incisions.
  • Mandibular swing or facial osteotomy for extensive oral cavity cancers.
  • Robotic‑assisted neck dissection to address cervical lymph node involvement with precision.

The table below compares key outcomes for traditional open surgery versus minimally invasive techniques:

Metric

Open Surgery

Minimally Invasive

 

Average Hospital Stay

7–10 days

3–5 days

Blood Loss

500–800 ml

150–300 ml

Facial Nerve Preservation

70 %

85 %

Recovery Time to Oral Intake

10–14 days

5–7 days

Post‑operative care includes intensive monitoring in a specialized neuro‑ICU, early mobilization, and coordinated rehabilitation. Detailed Treatment Details are discussed with patients before surgery, covering potential risks, expected functional outcomes, and the timeline for adjuvant therapies if needed.

Radiation Therapy Techniques

Radiation therapy offers a non‑invasive option to eradicate residual microscopic disease, shrink unresectable tumors, or serve as the primary modality for radiosensitive malignancies. Liv Hospital’s radiation oncology department features linear accelerators equipped with intensity‑modulated radiation therapy (IMRT), volumetric‑modulated arc therapy (VMAT), and stereotactic radiosurgery (SRS) capabilities.

Key techniques include:

  • IMRT – delivers highly conformal dose distributions, sparing adjacent critical structures such as the optic nerves.
  • Proton Therapy (available through partner centers) – provides a distinct Bragg peak, reducing exit dose and protecting healthy tissue.
  • SRS/SRT – high‑precision, high‑dose treatments for small, well‑defined lesions, often completed in 1–5 sessions.
  • Concurrent Chemoradiation – combines systemic agents with radiation to enhance tumor radiosensitivity.

Typical treatment courses span 5–7 weeks for conventional fractionation (2 Gy per session) or shorter hypofractionated schedules for select cases. Advanced imaging (CT‑simulation, MRI‑fusion) ensures accurate target delineation, while daily image guidance verifies patient positioning.

Patients receive a detailed schedule, side‑effect management plan, and nutritional counseling as part of the comprehensive Treatment Details package.

Systemic Therapies and Clinical Trials

Systemic therapy encompasses chemotherapy, targeted agents, immunotherapy, and emerging cellular treatments. The choice of regimen depends on tumor histology, molecular profile, and prior treatment exposure.

Common systemic options for head cancer include:

  • Platinum‑based chemotherapy (cisplatin or carboplatin) – backbone for many concurrent chemoradiation protocols.
  • EGFR inhibitors (cetuximab) – effective for squamous cell carcinoma of the head and neck.
  • PD‑1/PD‑L1 checkpoint inhibitors (nivolumab, pembrolizumab) – harness the immune system to attack tumor cells.
  • Targeted therapies (e.g., bevacizumab for VEGF‑driven tumors) based on specific genetic alterations.

Liv Hospital actively participates in international clinical trials, offering patients access to novel agents such as CAR‑T cell therapy and next‑generation tyrosine kinase inhibitors. Enrollment criteria, trial phases, and potential benefits are discussed transparently during the treatment planning session.

The following list outlines typical steps in a systemic therapy regimen:

  1. Baseline blood work and organ function assessment.
  2. Administration of the first cycle under close observation.
  3. Weekly toxicity evaluation and dose adjustment if needed.
  4. Imaging reassessment after 2–3 cycles to gauge response.
  5. Continuation or transition to maintenance therapy based on outcomes.

All systemic Treatment Details are individualized, with supportive care measures—including anti‑emetics, growth‑factor support, and psychosocial counseling—integrated into the patient’s overall plan.

Post‑Treatment Care and Rehabilitation

Recovery extends beyond the completion of active therapy. Liv Hospital’s survivorship program focuses on functional restoration, surveillance, and quality‑of‑life enhancement. A coordinated team of physiatrists, speech‑language pathologists, dietitians, and mental‑health professionals creates a tailored rehabilitation roadmap.

Core components of post‑treatment care:

  • Regular imaging follow‑up (MRI or PET‑CT) every 3–6 months for the first two years.
  • Comprehensive neurological and otolaryngological examinations to detect early recurrence.
  • Physical therapy to address neck stiffness, balance, and endurance.
  • Speech and swallowing therapy for patients who underwent oral or laryngeal surgery.
  • Psychological support groups and counseling to manage anxiety, depression, or adjustment disorders.

Nutrition plays a pivotal role in healing; dietitians design high‑protein, calorie‑dense meal plans, often supplemented with enteral feeding if oral intake is limited. Pain management follows a multimodal approach, combining medication, physiotherapy, and complementary modalities such as acupuncture.

By integrating these services, Liv Hospital ensures that the comprehensive Treatment Details extend into a holistic survivorship experience, empowering patients to regain independence and enjoy a meaningful post‑cancer life.

Why Choose Liv Hospital?

Liv Hospital combines JCI accreditation, a multilingual international patient team, and cutting‑edge technology to deliver world‑class head cancer care. Our specialists collaborate across borders, offering seamless coordination of diagnostics, surgery, radiation, and systemic therapy. International patients benefit from personalized travel assistance, interpreter services, and comfortable accommodation options, allowing them to focus solely on recovery.

Ready to discuss your personalized treatment plan? Contact our International Patient Services team today to schedule a virtual consultation and start your journey toward healing at Liv Hospital.

30 Years of
Excellence

Trusted Worldwide

With patients from across the globe, we bring over three decades of medical

Book a Free Certified Online
Doctor Consultation

Clinics/branches
GDPR
Group 346 LIV Hospital

Reviews from 9,651

4,9

Was this article helpful?

Was this article helpful?

We're Here to Help.
Get in Touch.

Send us all your questions or requests, and our expert team will assist you.

Doctors
GDPR

FREQUENTLY ASKED QUESTIONS

What are the main types of head cancer and how are they staged?

Head cancer comprises a variety of malignancies such as glioblastoma, meningioma, nasopharyngeal carcinoma, and salivary gland tumors. Staging follows the American Joint Committee on Cancer (AJCC) criteria, which assess tumor size (T), nodal involvement (N), and distant metastasis (M). The stage determines treatment intensity and prognosis. For example, Stage I (T1 N0 M0) indicates a small, localized tumor, while Stage IV (T4 N2/N3 M1) reflects extensive invasion and distant spread. Accurate staging guides multidisciplinary planning at Liv Hospital.

Liv Hospital follows a multidisciplinary diagnostic pathway. High‑resolution MRI with contrast maps soft‑tissue involvement, while CT evaluates bone structures. PET‑CT detects metabolic activity and distant disease. Image‑guided core needle or stereotactic biopsies provide histopathology, and genomic profiling identifies actionable mutations. All data are discussed in a weekly tumor board that includes neurosurgeons, radiation oncologists, medical oncologists, radiologists, and specialized nurses, ensuring a comprehensive and personalized treatment plan.

Liv Hospital offers both traditional and minimally invasive surgeries. Craniotomy provides direct access for intracranial tumors. Transnasal endoscopic surgery treats sinonasal and skull‑base lesions with no external incisions. Extensive oral cavity cancers may require mandibular swing or facial osteotomy. Robotic‑assisted neck dissection precisely removes cervical lymph nodes while preserving surrounding structures. Advanced image‑guided navigation and intra‑operative MRI enhance accuracy, reduce blood loss, and improve functional outcomes such as speech and swallowing.

Liv Hospital’s radiation oncology department is equipped with linear accelerators capable of intensity‑modulated radiation therapy (IMRT) and volumetric‑modulated arc therapy (VMAT), delivering highly conformal doses while sparing critical structures like the optic nerves. Stereotactic radiosurgery (SRS) and stereotactic radiotherapy (SRT) treat small, well‑defined lesions in 1–5 sessions. Through partner centers, patients can access proton therapy, which offers a Bragg peak to minimize exit dose. For radiosensitive tumors, concurrent chemoradiation combines systemic agents with radiation to increase tumor kill.

After active treatment, Liv Hospital’s survivorship program offers a structured rehabilitation roadmap. Patients receive MRI or PET‑CT scans every 3–6 months for the first two years, along with comprehensive neurological and otolaryngological examinations to detect recurrence early. Physical therapy addresses neck stiffness and balance, while speech‑language pathologists work on swallowing and voice restoration. Dietitians design high‑protein, calorie‑dense meals, sometimes supplemented with enteral feeding. Psychological counseling and support groups help manage anxiety, depression, and adjustment issues, ensuring a holistic recovery.

Spine Hospital of Louisiana

How helpful was it?

helpful
GDPR
helpful
GDPR
helpful
GDPR